Skip to content

Virtual Reality to Improve Satisfaction in Hysteroscopy Patients

Virtual Reality to Improve Satisfaction in Patients Undergoing Hysteroscopy: A Single-centre Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04862598
Acronym
VIP
Enrollment
192
Registered
2021-04-28
Start date
2021-03-24
Completion date
2022-06-01
Last updated
2021-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysteroscopy, Patient Satisfaction, Virtual Reality

Keywords

Virtual Reality, Hysteroscopy, Iowa Satisfaction Scale, Sedation

Brief summary

This study aims to investigate whether viewing an immersive virtual reality (VR) image through a VR headset during elective hysteroscopy under Registered Nurse (RN) led sedation with fentanyl and midazolam plus local anesthesia (monitored anesthetic care) will improve patient satisfaction with their anesthesia. Patients will be randomized to either receive usual care or usual care plus VR. Satisfaction will be measured by asking patients to complete a post-procedure survey consisting of 11 questions.

Detailed description

Purpose: To determine whether viewing an immersive VR image (viewed over an Oculus Quest VR headset) during hysteroscopy can improve patient satisfaction with their anesthesia (sedation plus local anesthesia). The VR image used in the study is Cosmic Flow: A Relaxing VR experience, which is freely available from Oculus. The patient will also wear headphones during the study which will play relaxing meditation music. Hypothesis: The use of immersive VR during elective hysteroscopy under sedation will improve patient satisfaction with their anesthesia by at least 20%, measured using the Iowa Satisfaction with Anesthesia Scale. Justification: Ambulatory hysteroscopy is conducted under general anesthesia or in the established Procedural Sedation Program. The latter involves Registered Nurse (RN) led sedation, consisting of the administration of sedation (midazolam) and analgesia (fentanyl) to reduce discomfort and anxiety. However, these medications have unwanted side-effects such as over-sedation and nausea, which can delay discharge and reduce patient satisfaction with their procedure. To minimize these complications, non-pharmacological therapy is of interest, as it aims to reduce the need and dosage of these medications. Virtual reality is one such non-pharmacological intervention which has been trialled in several settings, and has been shown to have beneficial effects on pain and anxiety during procedures such as wound dressing changes, upper GI endoscopies and dental procedures. Virtual reality use in the healthcare setting is currently in an early phase of research, and more study is needed on effects of VR on precise outcomes such as patient satisfaction, which is an important marker for quality in healthcare. Objectives: The objective is to study patient reported satisfaction with their anesthesia (sedation plus local anesthesia) when they receive standard care to when they receive standard care plus viewing an immersive VR image during their hysteroscopy procedure. Research Design: This is a randomized controlled trial involving data collection before, during and after the hysteroscopy procedure. Statistical Analysis: The primary outcome in change in patient satisfaction scores will be compared using paired t-test. For secondary outcomes, all continuous data will be compared using t-test or Mann-Whitney U test as appropriate. Incidence and proportion outcomes will be analyzed using Fisher exact test.

Interventions

DEVICEOculus Virtual Reality

The patient will receive standard care, augmented with virtual reality. Their post-operative satisfaction score will be recorded.

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Indications for hysteroscopy under RN-provided sedation

Exclusion criteria

* Inability to provide informed consent to participate in the study (e.g. significant language barrier) * Severe cognitive impairment * Chronic benzodiazepine use * Chronic opioid use * Presence or history of psychotic psychiatric disorders * Presence or history of seizure disorders * Visual acuity \<1 with correction * Hearing impairment requiring correction

Design outcomes

Primary

MeasureTime frameDescription
Patient Satisfaction15 minutes post-operativelyChange in post-procedure patient satisfaction score (Iowa Satisfaction Scale) of at least 0.6 between the Virtual Reality group and the control group. High scores are better than low scores which are worse. Scores range from -3 (completely unsatisfied) to 3 (completely satisfied)

Secondary

MeasureTime frameDescription
Patient anxiety scores before and after the procedure30 minutes before operation (one anxiety score). 15 minutes after operation (one anxiety score). On a 10 point Likert anxiety scale (0-10) high scores are more anxious and low scores are less anxious.10-point Likert Scale
Total Fentanyl dose45 minutes throughout the operationTotal IV Fentanyl dose in mcgs during the procedure
Total Midazolam dose45 minutes throughout the operationTotal IV Midazolam dose in mgs during the procedure
Occurrence of intraoperative hemodynamic changes45 minutes throughout the operationIncrease/decrease of 30 percent of SBP or HR compared to baseline
Incidence of early termination of VR experienceNoted during the procedureNoting whether the patient decides to terminate the VR experience before the end of their procedure.
Proportion of patients wishing to use the technology againNoted 15 minutes after the operationYes/No response
Immersion perception score of the VR system15 minutes after the operation.10 point Likert scale. On a 10 point Likert immersion scale (0-10) high scores are more immersed and low scores are less immersed.
Incidence of desaturation45 minutes throughout the operationPulse oxygen saturation \<90 percent

Other

MeasureTime frameDescription
Reason for early termination of VR experience45 minutes throughout the operationReasons may include: Patient desire/Medical decision/Nausea/Vomiting/Dizziness/ Headache/Device failure/ other

Countries

Canada

Contacts

Primary ContactHelen K Parker, FRCA
helenkparker22@gmail.com6048752158
Backup ContactCyrus Bhiladvala, B.Sc
cyrus.bhiladvala@cw.bc.ca6048752158

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026